Anthrax vaccination induced anti-lethal factor IgG: fine specificity and neutralizing capacity.
about
Bacillus anthracis edema factor substrate specificity: evidence for new modes of actionAlternative pre-approved and novel therapies for the treatment of anthraxA genome-wide association study of host genetic determinants of the antibody response to Anthrax Vaccine AdsorbedProtective antigen-specific memory B cells persist years after anthrax vaccination and correlate with humoral immunityPreparation and evaluation of human-murine chimeric antibody against protective antigen of Bacillus anthracis.Humoral responses to independent vaccinations are correlated in healthy boosted adultsExploiting human memory B cell heterogeneity for improved vaccine efficacy.MHC class II and non-MHC class II genes differentially influence humoral immunity to Bacillus anthracis lethal factor and protective antigen.Vector-mediated selective expression of lethal factor, a toxic element of Bacillus anthracis, damages A549 cells via inhibition of MAPK and AKT pathways.Stochastic humoral immunity to Bacillus anthracis protective antigen: identification of anti-peptide IgG correlating with seroconversion to Lethal Toxin neutralizationQuantitative Determination of Lethal Toxin Proteins in Culture Supernatant of Human Live Anthrax Vaccine Bacillus anthracis A16R.Characterization of the native form of anthrax lethal factor for use in the toxin neutralization assay.Human leukocyte antigens and cellular immune responses to anthrax vaccine adsorbed.Anthrax lethal toxin and the induction of CD4 T cell immunity.Host immunity to Bacillus anthracis lethal factor and other immunogens: implications for vaccine design.Anthrax Vaccine Precipitated induces Edema Toxin-neutralizing, Edema Factor-specific antibodies in human recipients.Lethal factor antibodies contribute to lethal toxin neutralization in recipients of anthrax vaccine precipitated.
P2860
Q27000357-AF220906-21BA-48A9-823B-FB743FA07BE8Q28075453-4A2E55C2-ABD8-4506-A751-08E122600F7EQ28943460-BE2CE8C5-9210-4773-A83D-2BBB3543DC18Q34101803-B113267D-014F-491C-858A-B3A771421009Q34486875-EC6B16D3-9E32-4426-96C5-603D7EA9DEA4Q35068548-D44F9E58-0185-49CB-AEF3-E46627BF4BB7Q35928222-44904BC5-60FD-41F4-9865-D87CAB35CB17Q36482706-36E2ACCD-76AC-4D51-AF67-0C6BCA1A9A47Q36619196-185EF671-741D-40D5-8716-DD78C9519E48Q36733960-897F6153-F778-443E-B897-3FB08BFA8738Q36735532-F77CC097-FAEB-4667-9207-0B3F00E6544DQ36970210-3CDC6876-6AB8-417B-A414-47FBDD6290B1Q36970735-F17F8ECD-21A2-4BF8-967D-E1FC2BDFCDEDQ38060730-344B90CD-3B14-4C50-8B1C-12716C235775Q38268596-9B32D7BB-D2FD-4AA6-AD5A-F5CB3B563611Q40064017-E822B5EB-79D3-472A-B157-5FB6AAEBCD23Q40213025-F164FD3E-9517-4C6D-B13A-1A781FB766FE
P2860
Anthrax vaccination induced anti-lethal factor IgG: fine specificity and neutralizing capacity.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Anthrax vaccination induced an ...... ity and neutralizing capacity.
@ast
Anthrax vaccination induced an ...... ity and neutralizing capacity.
@en
type
label
Anthrax vaccination induced an ...... ity and neutralizing capacity.
@ast
Anthrax vaccination induced an ...... ity and neutralizing capacity.
@en
prefLabel
Anthrax vaccination induced an ...... ity and neutralizing capacity.
@ast
Anthrax vaccination induced an ...... ity and neutralizing capacity.
@en
P2093
P2860
P1433
P1476
Anthrax vaccination induced an ...... ity and neutralizing capacity.
@en
P2093
A Darise Farris
Jimmy D Ballard
Lori Garman
Renata J M Engler
Sherry R Crowe
P2860
P304
P356
10.1016/J.VACCINE.2011.03.011
P407
P577
2011-03-21T00:00:00Z